SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN SMALL CHOROIDAL MELANOMAS AND CHOROIDAL NEVI.

"Supported in part by a Massachusetts Lions Club Grant, a Research to Prevent Blindness Challenge Grant, and the Yale School of Medicine Medical Student Research Fellowship. J. S. Duker receives research support from Carl Zeiss Meditec (Jena, Germany) and Optovue Inc (Fremont, CA). He is a consultant at Allergan Pharmaceuticals (Dublin, Ireland), Aura Biosciences (Cambridge, MA), Bausch Health (Laval, Canada), Novartis (Basel, Switzerland), and Roche (Basel, Switzerland). He is a director of entity at Sesen Bio (Cambridge, Massachusetts) and an employee of EyePoint Pharma (Watertown, MA). He is a shareholder at Hemera Biosciences (Waltham, MA). N. K. Waheed is a consultant for Topcon (Tokyo, Japan), Roche/Genentech (San Francisco, California), Regeneron (Tarrytown, New York), Apellis (Waltham, Massachusetts), Astellas (Tokyo, Japan), Boehringer Ingelheim (Ingelheim, Germany), and Novartis (Basel, Germany); she is a speaker for Nidek Medical Products (Gamagori, Japan) and Topcon (Tokyo, Japan); she is an officer of entity at Gyroscope (Ambler, Pennsylvania); she has a personal financial interest in the Boston Imaging Reading Center (Boston, Massachusetts) and Ocudyne. The remaining authors have no conflicting interests to disclose."

"Supported in part by a Massachusetts Lions Club Grant, a Research to Prevent Blindness Challenge Grant, and the Yale School of Medicine Medical Student Research Fellowship. J. S. Duker receives research support from Carl Zeiss Meditec (Jena, Germany) and Optovue Inc (Fremont, CA). He is a consultant at Allergan Pharmaceuticals (Dublin, Ireland), Aura Biosciences (Cambridge, MA), Bausch Health (Laval, Canada), Novartis (Basel, Switzerland), and Roche (Basel, Switzerland). He is a director of entity at Sesen Bio (Cambridge, Massachusetts) and an employee of EyePoint Pharma (Watertown, MA). He is a shareholder at Hemera Biosciences (Waltham, MA). N. K. Waheed is a consultant for Topcon (Tokyo, Japan), Roche/Genentech (San Francisco, California), Regeneron (Tarrytown, New York), Apellis (Waltham, Massachusetts), Astellas (Tokyo, Japan), Boehringer Ingelheim (Ingelheim, Germany), and Novartis (Basel, Germany); she is a speaker for Nidek Medical Products (Gamagori, Japan) and Topcon (Tokyo, Japan); she is an officer of entity at Gyroscope (Ambler, Pennsylvania); she has a personal financial interest in the Boston Imaging Reading Center (Boston, Massachusetts) and Ocudyne. The remaining authors have no conflicting interests to disclose."